Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial'. Together they form a unique fingerprint.